Norman C. Selby

Norman serves on the board of directors of Infinity Pharmaceuticals, Inc., Merz GmbH & Co. KGaA, Metamark Genetics, Inc., National Parks Conservation Association, Ralph Lauren Center, Ulthera, Inc., Memorial Sloan-Kettering Cancer Center, and Central Park Conservancy, Inc. Norman was previously a Senior Advisor with Perseus LLC, Chairman of Windhover Information, Inc., President & Chief Executive Officer of TransForm Pharmaceuticals, Inc., Executive Vice President of Citicorp, Inc., Chief Operating Officer of New York Blood Center, Inc., Director & Senior Partner of McKinsey & Co., Inc., and Chief Executive Officer of Reimbursement Intelligence. He has also served on the board at Ascenta Therapeutics, Inc., Physicians Interactive Holdings LLC, NanoBio Corp., Millennium Pharmaceuticals, Inc., BioForm Medical, Inc., KEW Group, Inc., and Physicians Interactive, Inc. Norman received a B.A. in Architecture from Yale College and an M.B.A. with Distinction from the Harvard Business School.